Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
Study of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
AustriaSafety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome
BelgiumStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
AustriaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
AustriaStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
BulgariaStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
BulgariaStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
AustriaStudy of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
AustriaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
AustriaPharmacokinetic Study of Ritlecitinib Tosilate in Healthy Adults: Oral Solution, Short‑and Long‑Duration Capsules Fed vs Fasted – for ulcerative colitis
BelgiumStudy of denikitug alone or in drug combination in adults with advanced microsatellite stable colorectal cancer
FranceThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
